We gebruiken cookies om ervoor te zorgen dat onze site zo soepel mogelijk draait. Als je doorgaat met het gebruiken van deze site, gaan we er vanuit dat je ermee instemt.
Paroxysmal supraventricular tachycardia (PSVT) is associated with significant morbidity and affects 1 in 300 people. This article reviews the contemporary management of PSVT and the potential role of intranasal etripamil, a recently FDA-approved intranasal calcium channel blocker that can be used to safely and effectively terminate PSVT in an outpatient setting and avoid urgent medical attention. When combined with the use of wearable devices, this paradigm shift of enabling patients to self-treat PSVT with an on-demand therapy provides another option to be considered in shared-decision making for PSVT management.
Paroxysmal supraventricular tachycardia (PSVT) is associated with significant morbidity and affects 1 in 300 people. This article reviews the contemporary management of PSVT and the potential role of intranasal etripamil, a recently FDA-approved intranasal calcium channel blocker that can be used to safely and effectively terminate PSVT in an outpatient setting and avoid urgent medical attention. When combined with the use of wearable devices, this paradigm shift of enabling patients to self-treat PSVT with an on-demand therapy provides another option to be considered in shared-decision making for PSVT management.
Extubation practices following cardiac surgery have undergone substantial evolution in recent years. Traditionally, patients remained intubated postoperatively due to safety concerns during the dynamic postoperative state. Advances in anesthetic techniques, physiologic monitoring, and perioperative care have since facilitated a shift toward earlier extubation—often within 6 hours of surgery—and, in select cases, immediate extubation in the operating room (ORE).1
Extubation practices following cardiac surgery have undergone substantial evolution in recent years. Traditionally, patients remained intubated postoperatively due to safety concerns during the dynamic postoperative state. Advances in anesthetic techniques, physiologic monitoring, and perioperative care have since facilitated a shift toward earlier extubation—often within 6 hours of surgery—and, in select cases, immediate extubation in the operating room (ORE).1